Clinical Trial Update: Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma [EARLY_Phase 1]

View source ↗

Summary

Update on an early-phase trial evaluating concurrent chemoradiation with 5-fluorouracil and mitomycin-C for anal canal cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Canal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Carcinoma of the Anal Canal | EARLY_Phase 1 | Status: COMPLETED